Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis.

Marrie RA, Dufault B, Tyry T, Cutter GR, Fox RJ, Salter A.

Mult Scler. 2019 Jun 4:1352458519852722. doi: 10.1177/1352458519852722. [Epub ahead of print]

PMID:
31161917
2.

Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Mult Scler. 2019 May 13:1352458519845836. doi: 10.1177/1352458519845836. [Epub ahead of print]

PMID:
31079537
3.

The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments.

Salter A, Fox RJ, Tyry T, Cutter G, Marrie RA.

Mult Scler Relat Disord. 2019 Jun;31:165-172. doi: 10.1016/j.msard.2019.04.014. Epub 2019 Apr 13.

PMID:
31063935
4.

A survey of risk tolerance to multiple sclerosis therapies.

Fox RJ, Cosenza C, Cripps L, Ford P, Mercer M, Natarajan S, Salter A, Tyry T, Cofield SS.

Neurology. 2019 Apr 2;92(14):e1634-e1642. doi: 10.1212/WNL.0000000000007245. Epub 2019 Mar 13.

5.

Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA.

Mult Scler Relat Disord. 2019 Apr;29:86-93. doi: 10.1016/j.msard.2019.01.031. Epub 2019 Jan 24.

PMID:
30690340
6.

Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.

Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA.

Neurol Clin Pract. 2018 Dec;8(6):472-481. doi: 10.1212/CPJ.0000000000000523.

PMID:
30588376
7.

Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis.

Neto LO, Gromisch ES, Sloan J, Tyry T, Foley FW.

Qual Life Res. 2019 Feb;28(2):389-397. doi: 10.1007/s11136-018-2023-0. Epub 2018 Oct 17.

PMID:
30334142
8.

Use of eHealth and mHealth technology by persons with multiple sclerosis.

Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A.

Mult Scler Relat Disord. 2019 Jan;27:13-19. doi: 10.1016/j.msard.2018.09.036. Epub 2018 Oct 2.

PMID:
30296732
9.

Development of the Multiple Sclerosis Resiliency Scale (MSRS).

Gromisch ES, Sloan J, Zemon V, Tyry T, Schairer LC, Snyder S, Foley FW.

Rehabil Psychol. 2018 Aug;63(3):357-364. doi: 10.1037/rep0000219. Epub 2018 Jul 19.

PMID:
30024200
10.

A survey of dietary characteristics in a large population of people with multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, Marrie RA.

Mult Scler Relat Disord. 2018 May;22:12-18. doi: 10.1016/j.msard.2018.02.019. Epub 2018 Feb 27.

PMID:
29510324
11.

Factors associated with excessive sitting time in multiple sclerosis.

Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A.

Mult Scler Relat Disord. 2018 Apr;21:71-77. doi: 10.1016/j.msard.2018.02.009. Epub 2018 Feb 10.

PMID:
29477021
12.

Judgment hurts: The psychological consequences of experiencing stigma in multiple sclerosis.

Cadden MH, Arnett PA, Tyry TM, Cook JE.

Soc Sci Med. 2018 Jul;208:158-164. doi: 10.1016/j.socscimed.2018.01.015. Epub 2018 Mar 6.

PMID:
29439818
13.

National estimates of self-reported sitting time in adults with multiple sclerosis.

Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A.

Mult Scler J Exp Transl Clin. 2018 Jan 19;4(1):2055217318754368. doi: 10.1177/2055217318754368. eCollection 2018 Jan-Mar.

14.

Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis.

Wang G, Marrie RA, Fox RJ, Tyry T, Cofield SS, Cutter GR, Salter A.

Mult Scler Relat Disord. 2018 Feb;20:16-21. doi: 10.1016/j.msard.2017.12.006. Epub 2017 Dec 14.

PMID:
29275057
15.

Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry.

Cofield SS, Thomas N, Tyry T, Fox RJ, Salter A.

Int J MS Care. 2017 Nov-Dec;19(6):303-312. doi: 10.7224/1537-2073.2016-091.

16.

Diet quality is associated with disability and symptom severity in multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, Marrie RA.

Neurology. 2018 Jan 2;90(1):e1-e11. doi: 10.1212/WNL.0000000000004768. Epub 2017 Dec 6.

PMID:
29212827
17.

Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants.

Cofield SS, Salter A, Tyry T, Crowe C, Cutter GR, Fox RJ, Marrie RA.

Neurol Clin Pract. 2017 Aug;7(4):333-343. doi: 10.1212/CPJ.0000000000000383.

18.

Trigeminal Neuralgia Commonly Precedes the Diagnosis of Multiple Sclerosis.

Fallata A, Salter A, Tyry T, Cutter GR, Marrie RA.

Int J MS Care. 2017 Sep-Oct;19(5):240-246. doi: 10.7224/1537-2073.2016-065.

19.

Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.

Marrie RA, Salter A, Tyry T, Cutter GR, Fox RJ.

Neurology. 2017 Sep 26;89(13):1429-1430. doi: 10.1212/WNL.0000000000004437. No abstract available.

PMID:
28947584
20.

A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.

Salter A, Thomas NP, Tyry T, Cutter GR, Marrie RA.

Mult Scler. 2018 Jun;24(7):951-962. doi: 10.1177/1352458517711274. Epub 2017 May 19.

PMID:
28524746
21.

Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis.

Marrie RA, Cutter GR, Tyry T, Cofield SS, Fox R, Salter A.

Mult Scler Relat Disord. 2017 Apr;13:87-92. doi: 10.1016/j.msard.2017.02.013. Epub 2017 Feb 20.

PMID:
28427709
22.

High hypothetical interest in physician-assisted death in multiple sclerosis.

Marrie RA, Salter A, Tyry T, Cutter GR, Cofield S, Fox RJ.

Neurology. 2017 Apr 18;88(16):1528-1534. doi: 10.1212/WNL.0000000000003831. Epub 2017 Mar 15.

PMID:
28298551
23.

Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis.

Reider N, Salter AR, Cutter GR, Tyry T, Marrie RA.

Res Nurs Health. 2017 Apr;40(2):143-152. doi: 10.1002/nur.21783. Epub 2017 Feb 6.

PMID:
28165143
24.

Employment and absenteeism in working-age persons with multiple sclerosis.

Salter A, Thomas N, Tyry T, Cutter G, Marrie RA.

J Med Econ. 2017 May;20(5):493-502. doi: 10.1080/13696998.2016.1277229. Epub 2017 Jan 25.

PMID:
28035846
25.

Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS.

Salter A, Tyry T, Wang G, Fox RJ, Cutter G, Marrie RA.

Neurol Clin Pract. 2016 Oct;6(5):397-408.

26.
27.

Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR.

Neurology. 2016 Jul 26;87(4):365-74. doi: 10.1212/WNL.0000000000002887. Epub 2016 Jun 29.

28.

Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.

Liu Y, Morgan C, Hornung L, Tyry T, Salter AR, Agashivala N, Belletti DA, Kim E, Fox RJ, Cofield SS, Cutter GR.

J Neurol Sci. 2016 Mar 15;362:121-6. doi: 10.1016/j.jns.2016.01.034. Epub 2016 Jan 19.

PMID:
26944131
29.

Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.

McKenzie T, Quig ME, Tyry T, Marrie RA, Cutter G, Shearin E, Johnson K, Simsarian J.

Int J MS Care. 2015 Nov-Dec;17(6):253-60. doi: 10.7224/1537-2073.2014-083.

30.

Risk tolerance to MS therapies: Survey results from the NARCOMS registry.

Fox RJ, Salter A, Alster JM, Dawson NV, Kattan MW, Miller D, Ramesh S, Tyry T, Wells BW, Cutter G.

Mult Scler Relat Disord. 2015 May;4(3):241-9. doi: 10.1016/j.msard.2015.03.003. Epub 2015 Mar 26.

PMID:
26008941
31.

Impact of multiple sclerosis relapse: The NARCOMS participant perspective.

Nickerson M, Cofield SS, Tyry T, Salter AR, Cutter GR, Marrie RA.

Mult Scler Relat Disord. 2015 May;4(3):234-40. doi: 10.1016/j.msard.2015.03.005. Epub 2015 Mar 27.

32.

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.

Salter AR, Marrie RA, Agashivala N, Belletti DA, Kim E, Cutter GR, Cofield SS, Tyry T.

Patient Prefer Adherence. 2014 Jul 4;8:971-9. doi: 10.2147/PPA.S49903. eCollection 2014.

33.

Health literacy association with health behaviors and health care utilization in multiple sclerosis: a cross-sectional study.

Marrie RA, Salter A, Tyry T, Fox RJ, Cutter GR.

Interact J Med Res. 2014 Feb 10;3(1):e3. doi: 10.2196/ijmr.2993.

34.

Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.

Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G, Campagnolo D.

Int J MS Care. 2013 Winter;15(4):194-201. doi: 10.7224/1537-2073.2012-034.

35.

The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.

Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA, Gromisch ES, Schairer D.

Mult Scler. 2014 Apr;20(5):610-6. doi: 10.1177/1352458513503598. Epub 2013 Sep 2.

PMID:
23999609
36.

Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought.

Marrie RA, Salter AR, Tyry T, Fox RJ, Cutter GR.

J Med Internet Res. 2013 Mar 17;15(4):e67. doi: 10.2196/jmir.2466.

37.

The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample.

Foley FW, Zemon V, Campagnolo D, Marrie RA, Cutter G, Tyry T, Beier M, Farrell E, Vollmer T, Schairer L.

Mult Scler. 2013 Aug;19(9):1197-203. doi: 10.1177/1352458512471876. Epub 2013 Jan 31.

PMID:
23369892
38.

Substantial burden of dizziness in multiple sclerosis.

Marrie RA, Cutter GR, Tyry T.

Mult Scler Relat Disord. 2013 Jan;2(1):21-8. doi: 10.1016/j.msard.2012.08.004. Epub 2012 Sep 25.

PMID:
25877451
39.

"Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry.

Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA.

Mult Scler. 2013 Jun;19(7):953-60. doi: 10.1177/1352458512469694. Epub 2012 Dec 20.

PMID:
23257618
40.

A pilot study of Latinos with multiple sclerosis: demographic, disease, mental health, and psychosocial characteristics.

Buchanan RJ, Zuniga MA, Carrillo-Zuniga G, Chakravorty BJ, Tyry T, Moreau RL, Vollmer T.

J Soc Work Disabil Rehabil. 2011;10(4):211-31. doi: 10.1080/1536710X.2011.622959.

PMID:
22126140
41.

APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.

Shi J, Tu JL, Gale SD, Baxter L, Vollmer TL, Campagnolo DI, Tyry TM, Zhuang Y, Kuniyoshi SM.

Cogn Behav Neurol. 2011 Sep;24(3):128-33. doi: 10.1097/WNN.0b013e31823380b5.

PMID:
21945984
42.

Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.

Marrie RA, Cutter G, Tyry T.

Mult Scler. 2011 Dec;17(12):1464-71. doi: 10.1177/1352458511414041. Epub 2011 Aug 15.

PMID:
21844067
43.

Cumulative impact of comorbidity on quality of life in MS.

Marrie RA, Horwitz R, Cutter G, Tyry T.

Acta Neurol Scand. 2012 Mar;125(3):180-6. doi: 10.1111/j.1600-0404.2011.01526.x. Epub 2011 May 26.

44.

Comparisons of Latinos, African Americans, and Caucasians with multiple sclerosis.

Buchanan RJ, Zuniga MA, Carrillo-Zuniga G, Chakravorty BJ, Tyry T, Moreau RL, Huang C, Vollmer T.

Ethn Dis. 2010 Autumn;20(4):451-7.

PMID:
21305836
45.

Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.

Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T.

Neuroepidemiology. 2011;36(2):85-90. doi: 10.1159/000323948. Epub 2011 Feb 1.

46.

A pilot study of young adults with multiple sclerosis: demographic, disease, treatment, and psychosocial characteristics.

Buchanan RJ, Minden SL, Chakravorty BJ, Hatcher W, Tyry T, Vollmer T.

Disabil Health J. 2010 Oct;3(4):262-70. doi: 10.1016/j.dhjo.2009.09.003. Epub 2009 Nov 26.

PMID:
21122795
47.

Association between comorbidity and clinical characteristics of MS.

Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T.

Acta Neurol Scand. 2011 Aug;124(2):135-41. doi: 10.1111/j.1600-0404.2010.01436.x. Epub 2010 Sep 29.

48.

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.

Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T.

Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.

49.

Age-related comparisons of people with multiple sclerosis: demographic, disease, and treatment characteristics.

Buchanan RJ, Chakravorty BJ, Tyry T, Hatcher W, Vollmer T.

NeuroRehabilitation. 2009;25(4):271-8. doi: 10.3233/NRE-2009-0525.

PMID:
20037220
50.

Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS.

Salter AR, Cutter GR, Tyry T, Marrie RA, Vollmer T.

Curr Med Res Opin. 2010 Feb;26(2):493-500. doi: 10.1185/03007990903500649.

PMID:
20014979

Supplemental Content

Support Center